Markets
About
XOR's Products and processes allow thoracic surgeons to better evaluate the suitability of a donor organ for transplantation. Prior to XOR, surgeons evaluated donor organs for transplantation on a look and feel basis with little solid data behind their decisions. This led to a donor organ rejection rate of approximately 85%. Many donated organs were going unused. XOR has developed processes and products that allow surgeons to evaluate the function of a donor organ outside of the body. A peer reviewed clinical trial of our processes shows that transplant centres can double the amount of donor organs they are accepting for transplantation by using our processes. Our products take that initial clinical gem and go further, taking the process mobile. This allows surgeons to expand the reach of our process, potentially recovering even more donor organs. We aim to change the field of lung transplantation by solving the long standing issue of donor organ supply to those in need.